| ID | Sequence | Length | GC content |
|---|---|---|---|
| PINK1-AS:1 | ACUUUGAAUUGCUAAAAGUGGCAUUUUUCCUAUGUGCAGUCACUCCUCU… | 4443 nt | 0.5102 |
| PINK1-AS:2 | UUCACCAGCUCCAUGCAGGGACAUCACAGGGCUGCCCUCCAUGAGCAGA… | 352 nt | 0.5142 |
No relevant information is available at the moment.
The literature review notes that the PINK1-AS is a therapeutic target in Parkinson's disease, where it targets PINK1 [Das et al. DOI:10.1080/21655979.2021.2003667].